Thanks to modern medicine, many cancer patients live longer, healthier lives. These hard-won victories have required a team effort; by working together, life science companies, clinical disease state experts, and community clinicians can dramatically improve cancer care for patients. All 3 entities play a vital role in developing life-saving treatments and ensuring that appropriate patients […]

Since the outbreak of COVID-19, telehealth has emerged as a way to continue patient care while minimizing risk of virus exposure. Interestingly, telehealth visits are not always on a screen. Many patients—particularly those who are older or have lower incomes—prefer to communicate with their providers via telephone over video visits. When parts of the US […]

The medical and pharmaceutical industries are dependent upon access to large amounts of patient data and utilizing this information in their research and the decisions they make regarding drug development and commercialization. Life science companies must continuously sift through mountains of clinical data. They are challenged with placing these data into their proper context to […]

Pancreatic cancer is one of the most difficult malignancies to manage. Multiple factors contribute to poor survival in these patients, including delayed diagnosis, rapid progression to metastatic disease, pain, and blood clots, all of which can complicate care. Outcomes have improved in recent decades, yet the current 5-year survival rate is still only 9%. The […]

2020 was an unforgettable year. COVID-19 sent shock waves across the globe, claiming more than 1.5 million lives with the end not yet in sight. In the wake of this tragedy, the pharmaceutical market raced to develop treatments. New vaccines for coronavirus have emerged in record time. In many ways, 2020 was a year of […]